首页> 美国政府科技报告 >Long-Term In Vivo Expression of a Murine Adenosine Deaminase Gene in RhesusMonkey Hematopoietic Cells of Multiple Lineages after Retroviral Mediated Gene Transfer into CD34+ Bone Marrow Cells. (Reannouncement with New Availability Information)
【24h】

Long-Term In Vivo Expression of a Murine Adenosine Deaminase Gene in RhesusMonkey Hematopoietic Cells of Multiple Lineages after Retroviral Mediated Gene Transfer into CD34+ Bone Marrow Cells. (Reannouncement with New Availability Information)

机译:在逆转录病毒介导的基因转移到CD34 +骨髓细胞后,在多个谱系的恒河猴造血细胞中长期体内表达小鼠腺苷脱氨酶基因。 (重新公布新的可用性信息)

获取原文

摘要

Retroviral mediated gene transfer into stem cells has been proposed as therapyfor many inherited hematopoietic diseases. Deficiency of the enzyme adenosine deaminase (ADA) results in depletion of T lymphocytes, causing severe combined immunodeficiency syndrome (SCIDS). In this report, we describe retroviral mediated gene transfer of a murine ADA cDNA into Rhesus monkey hematopoietic stem cells. Immunoselected CD34(+) bone marrow cells were exposed to medium containing the ADA retrovirus during culture on a stromal cell line engineered to express the transmembrane form of stem cell factor. After infusion of autologous, transduced cells into irradiated recipients, gene transfer was observed in all three monkeys. The ADA provirus was detected in 2% of circulating granulocytes and T cells from 100 days post-transplantation to longer than 1 year and in B cells from 250 days post-transplantation and beyond. Mouse ADA activity was detected in peripheral blood cells at approximately 3% the activity of monkey ADA. Thus, we have shown gene transfer into re-populating cells that contribute to all hematopoietic lineages with persistent gene expression. These data provide support for the use of stem cell targeted gene transfer for therapy of ADA deficiency.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号